Med Schools Withdraw from U.S. News List, but Say Hospital Rankings Are Separate
A number of high-performing medical schools that have withdrawn from the annual U.S. News & World Report rankings also have related hospitals that also regularly top the outlet’s “Best Hospitals” list. So, what might the medical school decampment mean for affiliated hospitals going forward? Indeed, several medical schools have said their decisions to not participate […]
Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancer
Clovis Oncology has voluntarily withdrawn the indication for rucaparib (Rubraca) as a third-line treatment in BRCA-mutated ovarian cancer after an overall survival (OS) analysis showed a signal for potential harm, according to a filing with the Securities and Exchange Commission (SEC). “Based on further discussions with the FDA following submission of ARIEL4 OS data previously […]